Corneal Implants Market Size By Tissue (Human Donor, Artificial Cornea), By Transplant (Anterior Lamellar Keratoplasty, Endothelial Lamellar Keratoplasty, Penetrating Keratoplasty), By Condition (Fungal Keratitis, Fuchs Dystrophy, Keratoconus), By End-use (Hospitals, Eye Clinics, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2030

Industry Overview

Corneal Implants Market size exceeded a valuation of over USD 320 million in 2021 and is projected to exhibit a 7% CAGR between 2022 and 2030. The growing prevalence of eye diseases across the globe is among the leading factors propelling the industry demand.
 

Eye conditions such as ocular hypertension and diabetic retinopathy have become significantly prevalent in recent years. Besides, the increasing burden of chronic diseases, such as hypertension and diabetes, has further contributed to several eye disorders, such as glaucoma, which is slated to transform the market dynamics.
 

Get more details on this report - Request Free Sample PDF
 

Limited availability of tissue donors to impede the corneal implants market progress

Although corneal implantation is a safe procedure, it involves a number of risks, including eye infection, swelling of the cornea, pressure within the eyeball, and rejection of donor cornea, which may hamper industry share. In addition, the limited availability of cornea tissues due to a shortage of donors may further emerge as a major growth restraining factor in the forthcoming years.
 

Increasing transplantation procedures to bolster the demand for human donor tissues

Corneal implants market from human donor tissue segment recorded a valuation of over USD 320 million in 2021. The segmental gains can be attributed to the rising awareness about corneal transplantation and eye tissue donation techniques. The extensive usage of non-optical grade corneas for therapeutic purposes has resulted in an upsurge in the utilization of donor corneas. Hence, taking note of these scenarios, the industry is set to register a lucrative growth.
 

Growing demand for minimally invasive interventions to foster the product adoption

Get more details on this report - Request Free Sample PDF
 

Corneal implants market from anterior lamellar keratoplasty (ALK) segment is predicted to depict over 7.5% CAGR through 2030. The increasing prevalence of several eye diseases and the subsequent surge in the number of anterior lamellar keratoplasty procedures are the major factors positively influencing segment expansion. The rising popularity of minimally invasive procedures, coupled with the fewer postoperative and intraoperative complications associated with the transplant technique, will increase segment share.
 

Rising disease prevalence to drive product demand for keratoconus surgeries

Corneal implants market from keratoconus segment is predicted to reach USD 150 million by 2030. Keratoconus is a common eye disease that affects the structure of the cornea and often results in loss of vision. The increased cognizance of corneal transplantation as an effective procedure to restore sight in those with the given condition will accelerate business trends. The inability of keratoconic corneas to handle ultraviolet light-induced oxidative stress and the expanding aging population may further propel the market size.
 

Intensive patient care to help hospitals come forth as a major end-use segment

Get more details on this report - Request Free Sample PDF
 

The hospitals segment is set to surpass USD 245 million by 2030. Hospital settings have the availability of robust healthcare infrastructure, emergency facilities, and skilled healthcare professionals, ensuring better patient outcomes. The presence of advanced medical equipment across these establishments translates into an increasing number of patient footfalls, thus augmenting the industry landscape.
 

Increasing elderly populace to spur market forecasts across North America

Get more details on this report - Request Free Sample PDF
 

North America corneal implants market was worth over USD 190 million in 2021. This is credited to the expanding geriatric population base and the greater susceptibility of aging people to several chronic ailments, such as diabetes. Diabetic people are more prone to developing eye diseases that lead to vision loss. National Eye Institute estimates suggest that over 30,000 Americans undergo corneal transplants to replace injured and diseased corneas, creating numerous growth opportunities for the regional industry.
 

Technological innovations to aid the competitive landscape

Leading companies in the corneal implants industry include AJL Ophthalmic SA (Intacs), Alabama Eye Bank, Alcon Inc.,  Aurolab, CorNeat Vision Ltd.,  CorneaGen, DIPOTEX, Florida Lions Eye Bank, Keramed, Inc., Massachusetts Eye, and Ear, Mediphacos, Microkpro Medical, and Presbia PLC. These players are focusing on leveraging cutting-edge technologies to develop advanced products to serve the increasingly expanding consumer base.
 

For instance, in January 2022, Microkpro declared that their MIOK Keratoprosthetics had received a regulatory nod from NMPA, the Chinese regulator of drugs and medical devices. MIOK is the world's first-ever artificial cornea approved so far. It requires no co-implantation of donor corneas and may help the company attract a significant number of customers.
 

Impact of COVID-19 on the corneal implants market trends

The corneal implants industry suffered a considerable setback due to the COVID-19 pandemic. The strict lockdown mandates imposed by the local and national authorities limited patients' hospital visits for non-essential treatments, especially during the first half of 2020. Ophthalmic procedures, including keratoplasty and sight-restoring surgeries, were put under elective surgical procedures that can be put on hold, further hampering the industry's revenue. Moreover, long waiting lists and a shortage of donors continued to stress the market outlook post-pandemic.
 

The corneal implants market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2030 for the following segments:

By Tissue Type

• Human donor
• Artificial cornea

By Transplant Type

• Anterior lamellar keratoplasty
• Endothelial lamellar keratoplasty
• Penetrating keratoplasty
• Others

By Condition

• Fungal Keratitis
• Fuchs’ dystrophy
• Keratoconus
• Others

By End-use

• Hospitals
• Eye Clinics
• Ambulatory Surgical Centers

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE